Review of the proceedings of the 2019 Genitourinary Cancers Symposium of the American society of clinical oncology (ASCO GU 2019)
Annual Genitourinary cancers symposium of the American society of clinical oncology (ASCO GU 2019) took place between 14th and 16th February in San Francisco (CA, USA) united more than 4,500professionals from 65 countries. In this article, a review of the most significant reports from the ASCO GU 20...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2019-04-01
|
| Series: | Onkourologiâ |
| Subjects: | |
| Online Access: | https://oncourology.abvpress.ru/oncur/article/view/929 |
| id |
doaj-5a072de4acda4b7dbca274db285bba7c |
|---|---|
| record_format |
Article |
| spelling |
doaj-5a072de4acda4b7dbca274db285bba7c2021-07-29T08:41:44ZrusABV-pressOnkourologiâ 1726-97761996-18122019-04-0115113714110.17650/1726-9776-2019-15-1-137-141836Review of the proceedings of the 2019 Genitourinary Cancers Symposium of the American society of clinical oncology (ASCO GU 2019)A. A. Kirichek0N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaAnnual Genitourinary cancers symposium of the American society of clinical oncology (ASCO GU 2019) took place between 14th and 16th February in San Francisco (CA, USA) united more than 4,500professionals from 65 countries. In this article, a review of the most significant reports from the ASCO GU 2019 is presented.https://oncourology.abvpress.ru/oncur/article/view/929combination immunotherapycombination immunotherapy and targeted therapybiomarkergenome profilingpd-l1 statussurvival |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
A. A. Kirichek |
| spellingShingle |
A. A. Kirichek Review of the proceedings of the 2019 Genitourinary Cancers Symposium of the American society of clinical oncology (ASCO GU 2019) Onkourologiâ combination immunotherapy combination immunotherapy and targeted therapy biomarker genome profiling pd-l1 status survival |
| author_facet |
A. A. Kirichek |
| author_sort |
A. A. Kirichek |
| title |
Review of the proceedings of the 2019 Genitourinary Cancers Symposium of the American society of clinical oncology (ASCO GU 2019) |
| title_short |
Review of the proceedings of the 2019 Genitourinary Cancers Symposium of the American society of clinical oncology (ASCO GU 2019) |
| title_full |
Review of the proceedings of the 2019 Genitourinary Cancers Symposium of the American society of clinical oncology (ASCO GU 2019) |
| title_fullStr |
Review of the proceedings of the 2019 Genitourinary Cancers Symposium of the American society of clinical oncology (ASCO GU 2019) |
| title_full_unstemmed |
Review of the proceedings of the 2019 Genitourinary Cancers Symposium of the American society of clinical oncology (ASCO GU 2019) |
| title_sort |
review of the proceedings of the 2019 genitourinary cancers symposium of the american society of clinical oncology (asco gu 2019) |
| publisher |
ABV-press |
| series |
Onkourologiâ |
| issn |
1726-9776 1996-1812 |
| publishDate |
2019-04-01 |
| description |
Annual Genitourinary cancers symposium of the American society of clinical oncology (ASCO GU 2019) took place between 14th and 16th February in San Francisco (CA, USA) united more than 4,500professionals from 65 countries. In this article, a review of the most significant reports from the ASCO GU 2019 is presented. |
| topic |
combination immunotherapy combination immunotherapy and targeted therapy biomarker genome profiling pd-l1 status survival |
| url |
https://oncourology.abvpress.ru/oncur/article/view/929 |
| work_keys_str_mv |
AT aakirichek reviewoftheproceedingsofthe2019genitourinarycancerssymposiumoftheamericansocietyofclinicaloncologyascogu2019 |
| _version_ |
1721252473136480256 |